Researchers have found that anticholinergic drugs, used to treat people with epilepsy, Parkinson’s disease, depression and incontinence, could increase the risk of dementia by almost 50 percent.
Following the death of a female cancer patient after a single dose of chemotherapy, the UK’s National Health Service has been criticized for failing to warn patients that the toxic treatment can kill them.
With research increasingly confirming that chemotherapy encourages the spread of cancer, a new article funded by a pharmaceutical company and published in The American Journal of Managed Care has claimed that reports of the demise of the toxic cancer treatment are ‘greatly exaggerated’.
NEWS Pharma company Insys Therapeutics has become the first opioid manufacturer to file for bankruptcy. This follows it agreeing a $225 settlement with the U.S. Department […]
NEWS In the first Australian case to link Bayer’s Roundup weedkiller with cancer, a Melbourne gardener has launched legal action against the multinational pharma company. COMMENT […]
NEWS The UK’s Royal College of Psychiatrists says patients seeking treatment for depression should be informed of the potential for “severe and long-lasting withdrawal symptoms.” COMMENT […]
NEWS Between 2012 and 2016 the drug industry donated over £57 million to UK patient organizations, a new analysis reveals. COMMENT Just as it does in most […]
Anticholinergic Drugs Could Increase Risk Of Dementia By Almost Fifty Percent